Effect of a novel ascorbic derivative, disodium isostearyl 2-O-L-ascorbyl phosphate on human dermal fibroblasts: Increased collagen synthesis and inhibition of MMP-1

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 4, 2008, Pages 563-568

  Shibayama, Hiroharu ^a,b   Hisama, Masayoshi ^b   Matsuda, Sanae ^b   Ohtsuki, Mamitaro ^a   Iwaki, Masahiro ^c  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Toyo Beauty Co Ltd   (Japan)

^c KINKI UNIVERSITY   (Japan)

Author keywords

Amphiphilic vitamin C derivative; Collagen synthesis; Disodium isostearyl 2 O L ascorbyl phosphate; Human skin fibroblast; VCP IS 2Na

Indexed keywords

ASCORBIC ACID; ASCORBIC ACID DERIVATIVE; COLLAGEN TYPE 1; DISODIUM ISOSTEARYL 2 O ASCORBYL PHOSPHATE; INTERSTITIAL COLLAGENASE; PHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; SKIN FIBROBLAST;

ASCORBIC ACID; CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MATRIX METALLOPROTEINASE 1; SKIN;

EID: 41849126434     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.563     Document Type: Article

References (27)

1. Stoker M. G. P., Rubin H., Nature (London), 215, 171-172 (1967).
2. Kleinman H. K., Klebe R. J., Martin G. R., J. Cell Biol., 88, 473-485 (1981).
3. Trelstad R. L., "The Role of Extracellular Matrix in Development," ed. by Trelstad R. L., Alan R. Liss, New York, 1984.
4. Yoshizato K., Taira T., Yamamoto N., Biomed. Res., 6, 61-71 (1985).
5. Reid L. M., Morrow B., Jubinsky P., Schwarz E., Gatmaitan Z., Ann. N.Y. Acad. Sci., 372, 354-370 (1981).
6. Prockop D. J., Kivirikko K. I., New Engl. J. Med., 311, 376-386 (1984).
7. Krane S. M., "Extracellular Matrix Biochemistry," ed. by Piez K. A., Reddi A. H., Elsevier, New York, 1984, pp. 413-463.
8. Bornstein P., Byers P. H., "Metabolic Control and Disease," 8th ed., ed. by Bondy P. K., Rosenberg L. E., W. B. Saunders, Philadelphia, 1980, pp.1089-1153.
9. Levin E. Y., Levenberg B., Kaufman S., J. Biol. Chem., 235, 2080-2086 (1960).
10. Friedman S., Kaufman S., J. Biol. Chem., 240, 4763-4773 (1965).
11. Hernandez Guerrero C. A., Vazquez Vela M. E., Herrerias Canedo T., Flores Herrera H., Meraz Cruz N., Ginecol. Obstet. Mex., 74, 3-12 (2006).
12. Schwarz R. I., Kleinamn P., Owens N., Ann. N.Y. Acad. Sci., 498, 172-185 (1987).
13. Sato P. H., Hall E. D., J. Neurochem., 58, 2263-2268 (1992).
14. Sciamanna M. A., Lee C. P., Arch. Biochem. Biophys., 305, 215-224 (1993).
15. Tajima S., Pinnell R. S., Biochem. Biophys. Res. Commun., 106, 632-637 (1982).
16. Lyons B. L., Schwarz R. I., Nucleic Acids Res., 12, 2569-2579 (1984).
17. Nusgens B. V., Humbert P., Rougier A., Richard A., Lapiere C. M., Eur. J. Dermatol., 12, 32-36 (2002).
18. Tolbert B. M., Downing M., Carlson R. W., Knight K., Baker E. M., Ann. N.Y. Acad. Sci., 1, 169-174 (1974).
19. Nomura H., Ishiguro T., Morimoto S., Chem. Pharm. Bull., 17, 387-393 (1969).
20. Imai Y., Usui T., Matsuzaki T., Yokotani H., Mina H., Aramaki Y., Jpn. J. Pharmacol., 17, 317-324 (1967).
21. Machlin L. J., Garcia F., Richter C. B., Spigel H. E., Brin M., Am. J. Clin. Nutr., 29, 825-831 (1976).
22. Hata R., Seikagaku, 60, 201-206 (1988).
23. Hata R., Senoo H., J. Cell Physiol., 138, 8-16 (1989).
24. Kuenzig W., Avenia R., Kamm J. J., J. Nutr., 104, 952-956 (1974).
25. Shibayama H., Ueda K., Yoshio K., Matsuda S., Hisama M., Miyazawa M., J. Oleo Sci., 54, 601-608 (2005).
26. Mosmann T., J. Immunol. Methods, 65, 55-65 (1983).
27. Kitagawa S., Li H., Sato S., Chem. Pharm. Bull., 45, 1354-1357 (1997).